Bismuth subcitrate potassium and metronidazole and tetracycline only product in oral dose form
|
Product containing precisely bismuth subcitrate potassium 140 milligram and metronidazole 125 milligram and tetracycline hydrochloride 125 milligram/1 each conventional release oral capsule (clinical drug)
Bismuth subcitrate potassium 140 mg and metronidazole 125 mg and tetracycline hydrochloride 125 mg oral capsule
Bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline hydrochloride 125 mg oral capsule
Id1222703002
StatusDefined
Has manufactured dose formOral capsule
Has unit of presentationCapsule
Has BoSStetracyclinehydrochloride
Has precise active ingredienttetracyclinehydrochloride
Has presentation strength denominator unitCapsule
Has presentation strength numerator unitmg
Has BoSSmetronidazol
Has precise active ingredientmetronidazol
Has presentation strength denominator unitCapsule
Has presentation strength numerator unitmg
Has BoSSBismuth subcitrate potassium
Has precise active ingredientBismuth subcitrate potassium
Has presentation strength denominator unitCapsule
Has presentation strength numerator unitmg